Cat.No. | Name | Information |
---|---|---|
M22469 | G3-C12 | G3-C12 is a galectin-3 binding peptide, with Kd of 88 nM, and shows anticancer activity. |
M14088 | OTX008 | OTX008 is a selective inhibitor of galectin-1. |
M9897 | GB1107 | GB1107 is a potent, selective, orally active galectin-3 inhibitor with Kd of 37 nM. GB1107 inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade. GB1107 potentiates the effects of a PD-L1 immune checkpoint inhibitor to increase expression of cytotoxic (IFN-γ, granzyme B, perforin-1, Fas ligand) and apoptotic (cleaved caspase-3) effector molecules. |
M9324 | TD139 | TD139 is a novel high-affinity inhibitor of the galectin-3 carbohydrate binding domain (Kd = 14 nM). |
M45360 | LYT-200 | LYT-200 is a monoclonal antibody that targets galectin-9 (galectin-9) and has antitumor activity. |
M41984 | Galectin-3 antagonist 1 | Galectin-3 antagonist 1 is a potent and selective Galectin-3 (Gal-3) antagonist with Kd value of 5.3 μM. |
M41983 | Galectin-3/galectin-8-IN-2 | Galectin-3/galectin-8-IN-2 is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 12.8 μM and 2.06 μM respectively. |
M41982 | Galectin-3/galectin-8-IN-1 | Galectin-3/galectin-8-IN-1 is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 4.12 μM and 6.04 μM respectively. |
M40747 | Belapectin | Belapectin, a galectin 3 inhibitor with a Ki value of 2.8 μM, reduces hepatic fibrosis and portal hypertension in rats, and can be used in studies related to non-alcoholic steatohepatitis (NASH). |
M29075 | Selvigaltin | Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.